GlassScriptPhysician profile
Tonya L Jackson
NPI 1558023572
$7,318.03
in general payments reported to CMS, 2019-2025
40 companies · $2,418 in 2025
The $2,418 reported for 2025 was more than what 95% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.04 · 2022: $588 · 2023: $1,845 · 2024: $2,454 · 2025: $2,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,717.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,043.46 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $945.51 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $877.19 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $699.55 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $490.10 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Amgen INC. | $342.24 | 2022-2025 | Otezla, Repatha, Repatha |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $318.98 | 2023-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $218.42 | 2022-2025 | Rexulti |
| Axsome Therapeutics, INC. | $195.91 | 2024-2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $183.61 | 2023-2025 | |
| Inspire Medical Systems, INC. | $179.64 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.88 | 2023-2025 | Jardiance, Synjardy |
| Aimmune Therapeutics, INC. | $154.28 | 2024-2025 | Zenpep |
| Mylan Specialty L.P. | $144.55 | 2022-2023 | Yupelri |
| Pfizer INC. | $133.28 | 2023-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $124.78 | 2025 | Symplicity G3 |
| Astellas Pharma US INC | $91.74 | 2023-2025 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $85.60 | 2022-2024 | Spravato, Xarelto |
| Merck Sharp & Dohme LLC | $80.52 | 2021-2023 | Verquvo, Belsomra |
| Scpharmaceuticals INC. | $73.76 | 2024-2025 | |
| Dexcom, INC. | $68.18 | 2024-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Exact Sciences Corporation | $67.92 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.19 | 2024-2025 | Xifaxan |
| Corcept Therapeutics | $65.65 | 2024-2025 | Korlym |
| Philips North America LLC | $58.07 | 2022-2024 | (Ck7) Extended Holter |
| Lundbeck LLC | $47.22 | 2025 | Vyepti |
| Shield Therapeutics INC | $45.37 | 2023-2024 | Accrufer |
| Sanofi-Aventis U.S. LLC | $41.77 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $38.90 | 2022-2024 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $38.71 | 2022 | |
| Almatica Pharma LLC | $36.19 | 2023-2024 | Loreev Xr, Gralise |
| Nestle Healthcare Nutrition INC. | $32.51 | 2023 | |
| Phathom Pharmaceuticals, INC. | $29.86 | 2025 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $26.83 | 2023-2025 | Zoryve, Livalo, Seglentis |
| Optinose US, INC. | $25.53 | 2024 | |
| Eisai INC. | $21.17 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.99 | 2024 | Trintellix |
| Scilex Pharmaceuticals INC. | $17.65 | 2022 | |
| Currax Pharmaceuticals LLC | $15.61 | 2022 | |
| Vanda Pharmaceuticals INC. | $14.71 | 2025 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonya Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.